Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELUTIA INC. Director's Dealing 2021

Dec 15, 2021

34697_dirs_2021-12-15_ec12b458-235a-4ef2-978b-268823de4385.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2021-12-14

Reporting Person: Englese Thomas (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-14 Class A Common Stock P 4580 $6.10 Acquired 5088 Direct

Footnotes

F1: Includes 508 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.